---
layout: post
title: "【图解年报】葵花药业：2021年归母净利润同比增长20.6%，约为7亿元"
date: 2022-04-21 19:17:49 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>葵花药业于2022年4月22日披露年报，公司2021年实现营业总收入44.6亿，同比增长28.9%；实现归母净利润7亿，同比增长20.6%；每股收益为1.21元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D20CCA7661AB9CD04452DAC7713F44AEA8_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D21B0B8A7697CE486F4940BFF56499C9D5_w800h400.jpg" alt=""><p><strong>期间费用率升高2.1%</strong></p><p>公司2021年营业成本18.2亿，同比增长25.4%，低于营业收入28.9%的增速，导致毛利率上升1.1%。期间费用率为39.6%，较上年升高2.1%。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D26B0FC7B0195860C769A1F2CF720063F6_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204212352268085>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)